A negative-pressure cup structure includes a negative-pressure cup body and a light therapy module. The negative-pressure cup body has a rim. The light therapy module is received in the negative-pressure cup body and includes a circuit board and multiple light-emitting diodes (LEDs) mounted on the circuit board and irradiating corresponding to the rim. Therefore, the negative-pressure cup structure further has functions of light therapy and skin care.

A skin care device can include a body including a battery and a grip electrode electrically connected to the battery, and a head connected to one end of the body. The head includes a contact electrode electrically connected to the battery and configured to come in contact with a skin of a user, and at least one ultraviolet light source disposed inside the head to face the contact electrode. Further, the contact electrode includes a fastening part fastened to the head and having at least one hole formed therein to correspond to the at least one ultraviolet light source, and a plurality of contact protrusions protruding from a top surface of the fastening part.

“DEVICE FOR TREATMENT OF WOUNDS AND MEANS OF USE”, deals with a new configuration applied to a device for wound treatment, for the medical field, where said device has the action of electromagnetic waves on parts of a patient's body, more specifically, a product for the improvement of the treatment of wounds of the body surface as those resulting from severe consequences and difficult healing, which can be used by diabetic or non-diabetic patients.

An apparatus for treating skin has a console with a user input device and a handpiece assembly. The handpiece assembly is configured to treat skin. A fluid line provides fluid communication between the console and the handpiece assembly. A manifold system is coupled to the console and controlled by the user input device. The manifold system is configured to hold releasably a plurality of fluid sources and deliver fluid from at least one of the plurality of fluid sources to the handpiece assembly.

Disclosed is a vibration stimulation device. The vibration stimulation device includes a box having a cavity, vibrators disposed in the cavity; light emitting elements disposed between the vibrators or disposed on the vibrators, an upper vibration layer configured to connect the vibrators and the light emitting elements to edges of the box on the cavity, and bumps disposed on the vibrators.

A handheld light therapy device may include a plurality of LEDs selected from a group of colors including red, green, blue, and near infrared, a first and second end, and a light color controller. The first end includes a handle for holding the apparatus and the second end includes the plurality of LEDs. The light color controller receives a light color signal from a user and outputs a polychromatic light corresponding to the light color input signal from at least two of the plurality of LEDs.

Certain exemplary embodiments can provide an apparatus and method for generating at least one radiation. The exemplary apparatus and/or method can selectively kill and/or affect at least one bacteria. For example, a radiation source first arrangement can be provided which is configured to generate at least one radiation having one or more wavelengths provided in a range of about 190 nanometers (nm) to about 230 nm, and at least one second arrangement can be provided which is configured to prevent the at least one radiation from having any wavelength that is outside of the range.

The present invention relates to a therapy for vitiligo. In particular the present invention provides a pharmaceutical composition comprising an alpha melanocyte stimulating hormone (alpha-MSH) analogue either alone, in combination with narrow band UVB and/or in combination with one or more corticosteroids, immunosuppressants, anti-inflammatory agents and/or photochemotherapeutic agents for the treatment or prevention of vitiligo.

The present disclosure relates generally to devices, systems, and methods for diagnosis and treatment via laser-treated skin and, more particularly, to devices, systems, and methods for inducing leakage or rupture of one or more blood vessels comprising the dermis for various diagnostic and therapeutic applications. Other aspects of the present disclosure can include methods for detecting one or more target analytes in a dermis of a subject, methods for facilitating skin-to-blood delivery of agent in a subject, and methods for collecting a fluid sample from the dermis of a subject.

Systems, methods, and computer-readable media for enabling ultraviolet radiation treatments are provided.